Medicare's GLP-1 Bridge Program: Weight Loss Medications for $50 Per Month
A new pilot program from the Centers for Medicare & Medicaid Services (CMS) may allow eligible Medicare beneficiaries to access certain GLP-1 weight loss medications for just $50 per month through December 31, 2027.
For more information about Medicare prescription drug coverage, visit Medicare Part D Information.
While you must be enrolled in a Medicare Part D prescription drug plan to qualify, the GLP-1 Bridge Program operates separately from your Part D coverage. Because of this, the $50 monthly copay does not count toward your Part D deductible or annual out-of-pocket costs.
Who May Qualify?
The GLP-1 Bridge Program is intended for Medicare beneficiaries who need weight management treatment but do not have coverage for GLP-1 medications through their Part D plan.
Covered Medications
Eligible beneficiaries may have access to:
• Foundayo (oral tablet)
• Wegovy (injection and tablet formulations)
• Zepbound (KwikPen only)
These medications must be prescribed specifically for weight loss and long-term weight management.
Eligible Medicare Plans
The program is available to beneficiaries enrolled in:
• Stand-alone Medicare Part D plans
• Medicare Advantage plans that include Part D drug coverage
• Special Needs Plans (SNPs)
• Dual-eligible beneficiaries enrolled in qualifying plans
Clinical Eligibility Requirements
To qualify, beneficiaries must meet one of the following criteria:
BMI of 35 or higher
OR
BMI of 30 or higher and have at least one weight-related condition, such as:
• Heart failure
• Uncontrolled hypertension
• Chronic kidney disease (Stage 3a or higher)
OR
BMI of 27 or higher and have at least one of the following:
• Prediabetes (based on American Diabetes Association guidelines)
• Previous heart attack
• Previous stroke
• Symptomatic peripheral artery disease
Individuals with a BMI below 27 are not eligible for the program.
How to Apply
Your healthcare provider must submit a prior authorization request through the program's clearinghouse before medication can be approved.
Important Limitations
The GLP-1 Bridge Program serves as the primary payer and does not coordinate benefits with Medicare Part D plans.
You may not qualify if you have:
• Type 2 diabetes
• Cardiovascular disease when the medication is prescribed to treat that condition
• Moderate-to-severe sleep apnea
• Metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver fibrosis
For official Medicare information, visit Medicare.gov or CMS.gov.
If you have questions about your Medicare coverage or prescription drug options, contact our office and we'll be happy to help.









